Characteristics | Low-risk patients | High-risk patients | ||||
---|---|---|---|---|---|---|
Long interval | Short interval | P | Long interval | Short interval | P | |
(n = 84) (%) | (n = 151) (%) | (n = 48) (%) | (n = 118) (%) | |||
Intrahepatic tumor size (cm) | Â | Â | 0.539 | Â | Â | 0.045 |
 Mean | 2.0 ± 1.3 | 1.9 ± 1.3 |  | 3.5 ± 3.3 | 2.6 ± 2.1 |  |
 Median | 1.7 (1.3) | 1.6 (1.0) |  | 2.5 (1.9) | 2.1 (1.3) |  |
Recurrence number | Â | Â | 0.394 | Â | Â | 0.383 |
 1 | 44 (52.4) | 86 (57.0) |  | 13 (27.1) | 38 (32.2) |  |
 2 | 12 (14.3) | 21 (13.9) |  | 4 (8.3) | 14 (11.9) |  |
 3 | 4 (4.8) | 5 (3.3) |  | 0 | 9 (7.6) |  |
 > 3 | 20 (23.8) | 29 (19.2) |  | 20 (41.7) | 41 (34.7) |  |
 Non-intrahepatic recurrence | 4 (4.8) | 10 (6.6) |  | 11 (22.9) | 16 (13.6) |  |
Recurrence location | Â | Â | 0.686 | Â | Â | 0.755 |
 Intrahepatic recurrence | 77 (91.7) | 136 (90.1) |  | 33 (68.8) | 84 (71.2) |  |
 Distant metastasis | 7 (8.3) | 15 (9.9) |  | 15 (31.3) | 34 (28.8) |  |
  Lung | 5 (6) | 8 (5.3) |  | 12 (25.0) | 27 (22.9) |  |
  Bone | 1 (1.2) | 1 (0.7) |  | 0 | 1 (0.8) |  |
  Others | 1 (1.2) | 6 (4.0) |  | 3 (6.3) | 6 (5.1) |  |
Recurrence BCLC stage (A, B and C) | Â | Â | 0.580 | Â | Â | 0.280 |
 A | 53 (63.1) | 103 (68.2) |  | 15 (31.3) | 49 (41.5) |  |
 B | 22 (26.2) | 28 (18.5) |  | 15 (31.3) | 31 (26.3) |  |
 C | 9 (10.7) | 20 (13.2) |  | 18 (37.5) | 38 (32.2) |  |
Curative intent treatment for recurrence | Â | Â | 0.430 | Â | Â | 0.388 |
 Yes | 29 (34.5) | 60 (39.7) |  | 7 (14.6) | 24 (20.3) |  |
 No | 55 (65.5) | 91 (60.3) |  | 41 (85.4) | 94 (79.7) |  |
Total treatment for recurrence (times) | ||||||
 Resection | 15 | 23 |  | 9 | 14 |  |
 Ablation | 38 | 124 |  | 23 | 76 |  |
 LT | 1 | 1 |  | 0 | 0 |  |
 TACE | 62 | 134 |  | 26 | 114 |  |
 Radiotherapy | 4 | 4 |  | 1 | 9 |  |